Evidence Gaps

Anti‐TNF discontinuation vs anti‐TNF continuation

Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in… 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1498 participants
Low

Anti‐TNF disease activity–guided dose tapering vs anti‐TNF continuation

Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in… 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 123 participants
Moderate

Anti‐TNF dose reduction vs anti‐TNF continuation

Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in… 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 501 participants
High